Point-of-Need Test of Cryptococcus Utilizing Aggregation-induced Emission-based Lateral Flow Immunoassay
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.5c06033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Simeng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing 100069, China. Hauptthemen laut MEDLINE: Cryptococcus, Cryptococcosis, Polysaccharides, Point-of-Care Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Municipal Health Commission, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Cryptococcus is a top-priority fungal pathogen designated by the World Health Organization. It induces pulmonary cryptococcosis and cryptococcal meningitis that are often misdiagnosed or underdiagnosed, owing to inherent limitations of existing detection methodologies, especially in resource-constrained point-of-need (PoN) settings. Although lateral flow immunochromatography (LFIA) is clinically recommended for its rapidity, it frequently lacks adequate sensitivity for the detection of early-stage infections, restricting its utility in PoN settings. Herein, we integrate the aggregation-induced emission (AIE) material TCBPE with LFIA to establish a novel rapid detection platform targeting glucuronoxylomannan (GXM). The TCBPE-PS-COOH (abbreviated as TCBPE-PS) composite was synthesized via swelling-mediated encapsulation of AIE material into carboxyl-modified polystyrene microspheres (PS-COOH), which enhanced the signal stability and fluorescence intensity. The developed AIE-integrated LFIA assay achieved a detection sensitivity of 12.3 ng/mL for GXM, and successfully detected Cryptococcus antigen in clinical serum samples with a DR value (T/C ratio) significantly higher than that of healthy controls. It delivers results within 12 min and exhibits 100% specificity against non-Cryptococcus pathogens, and the sensitivity for clinical samples is 100%. These findings advance the application of AIE materials in fungal point-of-need testing. Moreover, it provides a strategy for developing sensitive, accurate, and user-friendly diagnostic tools with quantified performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing 100069, China.
- Beijing Key Laboratory of Environment and Aging, Beijing 100069, China.
- Department of Respiratory and Critical Care, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
ORCID-Profile: Yueyue Chen, Rongzhang Hao
Förderung
- National Key Research and Development Program of China
- Beijing Municipal Health Commission
- Natural Science Foundation of Beijing Municipality
- Beijing Nova Program
- National Science and Technology Major Project
Zitieren
APA
Zhang, S., Wang, Z., Liu, H., Zhao, Z., Chen, Y., Xue, X., & Hao, R. (2026). Point-of-Need Test of Cryptococcus Utilizing Aggregation-induced Emission-based Lateral Flow Immunoassay. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c06033
Vancouver
Zhang S, Wang Z, Liu H, Zhao Z, Chen Y, Xue X, et al. Point-of-Need Test of Cryptococcus Utilizing Aggregation-induced Emission-based Lateral Flow Immunoassay. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.5c06033
BibTeX
@article{Zhang2026,
author = {Zhang, Simeng and Wang, Zixuan and Liu, Hao and Zhao, Ziqi and Chen, Yueyue and Xue, Xinying and Hao, Rongzhang},
title = {Point-of-Need Test of Cryptococcus Utilizing Aggregation-induced Emission-based Lateral Flow Immunoassay},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.5c06033}
}
EUVIMED